Tavşan, E. Et Al. 2023. TGF-β1 receptor inhibitor SB-431542 inhibits proliferation of metastatic breast carcinoma cells and enhances anti-tumoral effects of Doxorubicin. . 20’th CIMT Annual Meeting. , (Mainz, Germany).

Tavşan, E., Shurin, G., Shurin, M., & Erin, N., (2023). TGF-β1 receptor inhibitor SB-431542 inhibits proliferation of metastatic breast carcinoma cells and enhances anti-tumoral effects of Doxorubicin. . 20’th CIMT Annual Meeting., Mainz, Germany

Tavşan, ESRA Et Al. "TGF-β1 receptor inhibitor SB-431542 inhibits proliferation of metastatic breast carcinoma cells and enhances anti-tumoral effects of Doxorubicin. ," 20’th CIMT Annual Meeting., Mainz, Germany, 2023

Tavşan, ESRA Et Al. "TGF-β1 receptor inhibitor SB-431542 inhibits proliferation of metastatic breast carcinoma cells and enhances anti-tumoral effects of Doxorubicin. ." 20’th CIMT Annual Meeting. , Mainz, Germany, 2023

Tavşan, E. Et Al. (2023) . "TGF-β1 receptor inhibitor SB-431542 inhibits proliferation of metastatic breast carcinoma cells and enhances anti-tumoral effects of Doxorubicin. ." 20’th CIMT Annual Meeting. , Mainz, Germany.

@conferencepaper{conferencepaper, author={ESRA TAVŞAN Et Al. }, title={TGF-β1 receptor inhibitor SB-431542 inhibits proliferation of metastatic breast carcinoma cells and enhances anti-tumoral effects of Doxorubicin. }, congress name={20’th CIMT Annual Meeting.}, city={Mainz}, country={Germany}, year={2023}}